ArticleEruptive Keratoacanthomas After Nivolumab Treatment of Stage III MelanomaAuthor:Danielle Y. Sullivan, BSPublish date: May 17, 2023Eruptive keratoacanthomas (KAs) are a rare buttransient adverse effect of programmed cell death protein 1 (PD-1) inhibitor therapy.Read More